Accelerating drug discovery through world class sample management

Compounds Australia, the national sample management facility, supports drug discovery from early-stage screening through to hit validation and lead optimisation.

Located within the Institute for Biomedicine and Glycomics, we provide cost-effective, end-to-end solutions for the storage, curation and distribution of both proprietary (closed) and open access compound libraries.

By outsourcing complex sample management and logistics to our expert team, researchers and organisations worldwide can focus on accelerating scientific discoveries and delivering impactful health outcomes.

Backed by specialist infrastructure, advanced technologies and deep industry expertise, we are transforming sample management practices across Australia to enable smarter, faster and more efficient drug discovery.

Our services

Compound libraries – Managed under open-, closed-, or specialised-access models. Storage – Tightly controlled storage environments protect sample integrity. Flexible plate formats – Assay-ready plates can be custom-formatted for screening, dose response, combination matrices, and pooling. Informatics – Industry standard inventory tracking and order management (Cenevo, Mosaic); Open Access compound search portal (Smart Compounds). LC-MS – Confirm identity and integrity of stored compounds. Assay-ready plates – distributed globally for seamless screening and analysis. Plates prepared to your specifications can be delivered to you, your collaborators or members of COMPOUNDS AUSTRALIA’s integrated screening network.  Integrated screening network – Accelerate discovery through access to target-based, phenotypic, and high-throughput screening capabilities partnered with Compounds Australia Screening capabilities co-located at Griffith University: Surface plasmon resonance Mass spectrometry Cell-based screening High-content imaging National capabilities (enabled by Therapeutic Innovation Australia): Biochemical assays Flow cytometry Cell-based screening, including organoid,  spheroid, and 3D models High-content live- and fixed- imaging

“Compounds Australia plays a critical role in maximising the impact of reNEW’s high-value compound collection. By enabling efficient access to reNEW’s library, Compounds Australia has made faster screening possible across the renew partner network, ensuring we get maximum value from this resource and accelerating our research progress.

Their team consistently goes beyond standard service delivery, working creatively with us to support the needs of researchers and partner organisations while overcoming logistical challenges that might otherwise slow discovery. We have complete confidence in Compounds Australia's management of the reNEW library to ensure long-term value of this important research asset.“

– Dr Kevin Watt

Associate Investigator, Novo Nordisk Foundation Center for Stem Cell Medicine, Murdoch Children's Research Institute

Connect with us

Follow us on LinkedIn and subscribe to our mailing list for news, opportunities, events, and updates from across the drug discovery community.

Funding

Compounds Australia is supported by fee-for-service contributions. Our equipment and facility purchases have been made possible with support from the following funding partners:

Therapeutic Innovation Australia logoAustralian Cancer Research Foundation logoQueensland Government logo

Contact details

Phone
(07) 3735 4445
Email
compounds-australia@griffith.edu.au
Location and postal address
Compounds Australia
Institute for Biomedicine and Glycomics
Griffith University
Building N75
Brisbane Innovation Park
Don Young Road
Nathan QLD 4111
Connect on socials

Enquiry

Privacy (required)

Your privacy is important to us. Information you supply will be handled strictly in accordance with our Privacy Statement.